77.92
Schlusskurs vom Vortag:
$79.45
Offen:
$79.16
24-Stunden-Volumen:
58,980
Relative Volume:
0.06
Marktkapitalisierung:
$6.67B
Einnahmen:
$1.15B
Nettoeinkommen (Verlust:
$96.70M
KGV:
71.49
EPS:
1.09
Netto-Cashflow:
$-161.99M
1W Leistung:
-10.59%
1M Leistung:
-17.31%
6M Leistung:
-16.34%
1J Leistung:
-30.19%
Healthequity Inc Stock (HQY) Company Profile
Firmenname
Healthequity Inc
Sektor
Branche
Telefon
801-727-1000
Adresse
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, TEM, BTSG, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
78.02 | 6.79B | 1.15B | 96.70M | -161.99M | 1.09 |
|
VEEV
Veeva Systems Inc
|
180.83 | 30.19B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
55.31 | 9.77B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.66 | 7.16B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
DOCS
Doximity Inc
|
27.13 | 5.12B | 550.17M | 201.35M | 232.07M | 1.00 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-05-22 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-03-25 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-04-02 | Bestätigt | JP Morgan | Overweight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-10-21 | Hochstufung | Goldman | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-12 | Eingeleitet | Goldman | Sell |
| 2022-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-03-30 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-12-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-07-02 | Eingeleitet | Stephens | Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-01-07 | Eingeleitet | BTIG Research | Neutral |
| 2020-12-08 | Bestätigt | Barrington Research | Outperform |
| 2020-12-02 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-14 | Eingeleitet | Guggenheim | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-03-17 | Bestätigt | Barrington Research | Outperform |
| 2019-10-07 | Eingeleitet | Goldman | Neutral |
| 2019-09-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-07-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-06-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-03-01 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-07 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-12-06 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-05-23 | Eingeleitet | BofA/Merrill | Buy |
| 2018-04-24 | Fortgesetzt | JP Morgan | Overweight |
| 2018-03-20 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-06 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Healthequity Inc Aktie (HQY) Neueste Nachrichten
Decliners Report: Is Snowflake Inc stock undervalued right nowJuly 2025 Snapshot & Daily Growth Stock Investment Tips - baoquankhu1.vn
Bessemer Group Inc. Raises Holdings in HealthEquity, Inc. $HQY - MarketBeat
Layoff Watch: Will HealthEquity Inc benefit from AI trendsQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Is There An Opportunity With HealthEquity, Inc.'s (NASDAQ:HQY) 45% Undervaluation? - 富途牛牛
Trading Systems Reacting to (HQY) Volatility - Stock Traders Daily
HealthEquity, Inc. (NASDAQ:HQY) Sees Large Decline in Short Interest - MarketBeat
HealthEquity, Inc. (HQY) Investor Outlook: Unpacking A 39% Potential Upside - DirectorsTalk Interviews
Here's Why HealthEquity (HQY) is a Strong Growth Stock - Yahoo Finance
HealthEquity, Inc. $HQY Stock Position Lowered by New York State Common Retirement Fund - MarketBeat
HealthEquity’s Fiscal Year-End Sets Stage for March Financial Disclosure - AD HOC NEWS
How HealthEquity’s GARP Profile and Accelerating Earnings Narrative At HealthEquity (HQY) Has Changed Its Investment Story - Sahm
US Market Wrap: How does MBOT correlate with NasdaqShare Buyback & Risk Managed Investment Signals - baoquankhu1.vn
Earnings Miss: Is HealthEquity Inc stock technically oversoldJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
HealthEquity Inc. (NASDAQ:HQY): A Prime GARP Candidate with Strong Growth and Reasonable Valuation - Chartmill
HealthEquity Inc (NASDAQ:HQY) Presents a Compelling Growth and Breakout Opportunity - Chartmill
Published on: 2026-01-28 07:33:41 - baoquankhu1.vn
Here's Why HealthEquity (NASDAQ:HQY) Has Caught The Eye Of Investors - Yahoo Finance
Strs Ohio Raises Holdings in HealthEquity, Inc. $HQY - MarketBeat
Published on: 2026-01-26 18:05:42 - baoquankhu1.vn
HealthEquity, Inc. (HQY) Investor Outlook: Explore the 41.63% Potential Upside and Analyst Confidence - DirectorsTalk Interviews
GDS Wealth Management Raises Stock Position in HealthEquity, Inc. $HQY - MarketBeat
How Healthequity Inc. (HQY) Affects Rotational Strategy Timing - Stock Traders Daily
Here's Why You Should Add HealthEquity Stock to Your Portfolio Now - sharewise.com
Did New FY 2027 Revenue Guidance and JPM Spotlight Just Shift HealthEquity's (HQY) Investment Narrative? - simplywall.st
Aug Sentiment: Is BlackRock Core Bond Trust stock a smart retirement pickMarket Performance Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Aug Spikes: Will HealthEquity Inc stock benefit from M AJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Published on: 2026-01-20 04:22:59 - baoquankhu1.vn
Profit Review: Does Knightscope Inc stock have upside surprise potentialBear Alert & Daily Volume Surge Signals - baoquankhu1.vn
The Truth About HealthEquity Inc: Why Wall Street Is Quietly Loading Up On HQY - AD HOC NEWS
We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt - 富途资讯
HealthEquity (NASDAQ:HQY) Rating Increased to Buy at Wall Street Zen - MarketBeat
Stephens Investment Management Group LLC Has $68.64 Million Stock Holdings in HealthEquity, Inc. $HQY - MarketBeat
HQYHealthEquity Sets Date to Announce Third Quarter Results - ADVFN
New York Gov. Hochul Reveals Cannabis Initiatives Aimed at Supply Chain, Health Equity - Cannabis Equipment News
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Yahoo Finance
HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
The Market's Not Diagnosing HealthEquity Accurately (NASDAQ:HQY) - Seeking Alpha
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2018 Financial Results - ADVFN
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2019 Financial Results - ADVFN
A Look At HealthEquity (HQY) Valuation As New Guidance And Split Analyst Calls Draw Attention - Sahm
HealthEquity Announces Year-End Sales Outlook, Presentation at JP Morgan Healthcare Conference - ADVFN
HealthEquity (NASDAQ:HQY) Trading Down 6.5%Here's Why - MarketBeat
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2027 - marketscreener.com
HealthEquity expects FY 2027 revenue between $1.38B and $1.41B; shares down over 7% - MSN
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test - TechStock²
HealthEquity drops after 2027 outlook misses estimates - TradingView — Track All Markets
Why Is HealthEquity’s Hot Streak Suddenly Faltering? - TipRanks
HealthEquity sees FY27 revenue $1.38B-$1.41B, consensus $1.41B - TipRanks
HealthEquity Expects Fiscal 2027 Revenue of $1.38 Billion to $1.41 Billion - marketscreener.com
HealthEquity Issues Confident Fiscal 2027 Outlook and Guidance - TipRanks
HealthEquity, Inc. Projects Fiscal Year 2027 Revenue Range and Reaffirms Fiscal Year 2026 Guidance - Quiver Quantitative
Finanzdaten der Healthequity Inc-Aktie (HQY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):